All In Biotech

Drug Trial Radar · NCT07772531

A Study to Evaluate BMS-986511 in Adults With Major Depressive Disorder

A Phase 2, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Monotherapy, Multicenter Study to Evaluate the Efficacy and Safety of BMS-986511 in Two Sequential Parts in Participants With Major Depressive Disorder

Last checked: Nov 19, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

200

Planned (sponsor's estimate)

Start

Oct 30, 2026

Primary completion

Nov 6, 2028

Study completion Nov 6, 2028

Sponsor

Lead sponsor
Bristol-Myers SquibbBristol Myers Squibb (BMY)
Sponsor type
Industry
First posted
Aug 19, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Sequential
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Study to Evaluate BMS-986511 in Adults with Major Depressive Disorder

Conditions

  • Major Depressive Disorder

Interventions

  • BMS-986511Drug

    Specified dose on specified days

  • PlaceboDrug

    Specified dose on specified days

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mean change from baseline in Hamilton Depression Rating Scale -17 Item (HDRS-17) total scoreTime frame: Up to Day 57

Locations

24 sites in 2 countries. Site status is shown where the registry gives one.

  • Local Institution - 0144

    Phoenix, Arizona · Not yet recruiting

  • Woodland International Research Group

    Little Rock, Arkansas · Recruiting

  • Woodland Research Northwest LLC

    Rogers, Arkansas · Recruiting

  • Local Institution - 0046

    Garden Grove, California · Not yet recruiting

  • Local Institution - 0042

    Glendale, California · Not yet recruiting

  • Local Institution - 0071

    Lemon Grove, California · Not yet recruiting

  • Local Institution - 0079

    Oakland, California · Not yet recruiting

  • Local Institution - 0050

    Upland, California · Not yet recruiting

  • Local Institution - 0007

    Jacksonville, Florida · Not yet recruiting

  • Local Institution - 0024

    Orlando, Florida · Not yet recruiting

  • CenExel CBH

    Atlanta, Georgia · Recruiting

  • Local Institution - 0044

    Gaithersburg, Maryland · Not yet recruiting

  • Local Institution - 0041

    Cedarhurst, New York · Not yet recruiting

  • Local Institution - 0069

    Mount Kisco, New York · Not yet recruiting

  • Local Institution - 0121

    Staten Island, New York · Not yet recruiting

  • Local Institution - 0086

    Columbus, Ohio · Not yet recruiting

  • Local Institution - 0027

    Oklahoma City, Oklahoma · Not yet recruiting

  • Local Institution - 0003

    Everett, Washington · Not yet recruiting

  • Local Institution - 0005

    Kladno, Czechia · Not yet recruiting

  • Local Institution - 0081

    Klecany, Czechia · Not yet recruiting

  • Local Institution - 0028

    Pilsen, Czechia · Not yet recruiting

  • Local Institution - 0080

    Prague, Czech Republic, Czechia · Not yet recruiting

  • Local Institution - 0111

    Prague, Praha 6, Czechia · Not yet recruiting

  • Local Institution - 0032

    Prague, Praha 8, Czechia · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.